Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_41457 | 15 | 0.31 | Mlig455_000251 | Neo: - Age: - |
NPFFR1 | Mlig455_000251 {REF} {Length: 3347} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.4]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=73.6, Expect=3e-13]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=74.3, Expect=1e-13]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=80.9, Expect=1e-15]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=65.9, Expect=5e-11]} {Smed: dd_Smed_v6_28214_0_1, dd_Smed_v6_28214_0_1, [Score=58.9, Expect=4e-09]} {RNA1310_90849} {RNA815_47833} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_41457 | 15 | 0.31 | Mlig455_000251 | Neo: - Age: - |
NPFFR1 | 2 | - | - | 1.000 | - | 1.000 | - | Mlig455_000251 {REF} {Length: 3347} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.4]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=73.6, Expect=3e-13]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=74.3, Expect=1e-13]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=80.9, Expect=1e-15]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=65.9, Expect=5e-11]} {Smed: dd_Smed_v6_28214_0_1, dd_Smed_v6_28214_0_1, [Score=58.9, Expect=4e-09]} {RNA1310_90849} {RNA815_47833} |
2. | MligTC455_15759 | 90 | 1.87 | Mlig455_011069 | Neo: - Age: - |
PCDH9 | 1.968 | - | - | 0.985 | - | 0.983 | - | Mlig455_011069 {REF} {Length: 3981} {Pfam: Cadherin domain [PF00028.19, score=243.4]; Cadherin-like [PF16184.7, score=38.3]; Cadherin-like [PF08266.14, score=33.4]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=271, Expect=2e-74]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=266, Expect=4e-73]} {Dmel: FBgn0001075, ft, fat, [Score=216, Expect=2e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=163, Expect=3e-40]} {Smed: dd_Smed_v6_16610_0_1, dd_Smed_v6_16610_0_1, [RH, Score=271, Expect=6e-76]} {RNA1310_20741} {RNA815_3048.1} |
3. | MligTC455_53346 | 17 | 0.35 | Mlig455_010821, Mlig455_010828 | Neo: - Age: Up-Down-Down |
CNGA3 | 1.897 | - | - | 0.911 | - | 0.986 | - | Mlig455_010821 {REF} {Length: 2277} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=67.8]; C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=60.3]; Ion transport protein [PF00520.33, score=50.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=614, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=609, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=559, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=538, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=629, Expect=0.0]} {RNA1310_57933} {RNA815_59167} Mlig455_010828 {REF} {Length: 794} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=45.0]; Cyclic nucleotide-binding domain [PF00027.31, score=27.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=219, Expect=1e-66]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=214, Expect=8e-65]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=205, Expect=2e-61]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=216, Expect=4e-65]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=249, Expect=1e-78]} {RNA1310_57933} {RNA815_16119} |
4. | MligTC455_11954 | 21 | 0.43 | Mlig455_056770 | Neo: - Age: - |
LHX6 | 1.843 | - | - | 0.856 | - | 0.987 | - | Mlig455_056770 {REF} {Length: 1956} {Pfam: Homeodomain [PF00046.31, score=63.1]; LIM domain [PF00412.24, score=52.0]} {Human: ENSG00000106852, LHX6, LIM homeobox 6, [Score=135, Expect=1e-35]; ENSG00000162624, LHX8, LIM homeobox 8, [Score=129, Expect=3e-33]} {Mouse: ENSMUSG00000026890, Lhx6, LIM homeobox protein 6, [Score=137, Expect=5e-36]} {Dmel: FBgn0013751, Awh, Arrowhead, [RH, Score=157, Expect=6e-45]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [RH, Score=159, Expect=1e-44]} {Smed: dd_Smed_v6_47123_0_1, dd_Smed_v6_47123_0_1, [RH, Score=222, Expect=1e-68]} |
5. | MligTC455_13007 | 32 | 0.67 | Mlig455_055548 | Neo: - Age: - |
PCDH11Y | 1.839 | - | - | 0.844 | - | 0.995 | - | Mlig455_055548 {REF} {Length: 4787} {Pfam: Cadherin domain [PF00028.19, score=284.6]; Cadherin-like [PF08266.14, score=46.3]; Cadherin-like [PF16184.7, score=42.7]; Cadherin prodomain like [PF08758.13, score=32.3]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=294, Expect=8e-84]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=294, Expect=1e-83]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=282, Expect=8e-80]} {Dmel: FBgn0001075, ft, fat, [Score=239, Expect=2e-64]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=202, Expect=1e-52]} {Smed: dd_Smed_v6_18373_0_1, dd_Smed_v6_18373_0_1, [Score=295, Expect=4e-84]} {RNA1509_54067} {RNA1310_21501} {RNA815_32416} |
6. | MligTC455_25245 | 34 | 0.7 | Mlig455_006162, Mlig455_029139, Mlig455_054138, Mlig455_065758, Mlig455_068467, Mlig455_071050 | Neo: - Age: - |
1.821 | - | - | 0.838 | - | 0.983 | - | Mlig455_006162 {REF} {Length: 1019} {Pfam: Repeat of unknown function (DUF1502) [PF07397.13, score=23.1]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.5]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=60.8, Expect=6e-10]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_029139 {REF} {Length: 1958} {Pfam: Domain of unknown function (DUF4834) [PF16118.7, score=25.2]; Repeat of unknown function (DUF1502) [PF07397.13, score=19.7]; Subunit CCDC53 of WASH complex [PF10152.11, score=19.2]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=82.4, Expect=3e-16]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_054138 {REF} {Length: 1019} {Pfam: Repeat of unknown function (DUF1502) [PF07397.13, score=22.9]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=80.1, Expect=3e-16]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_065758 {REF} {Length: 977} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=73.9, Expect=3e-14]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_068467 {REF} {Length: 1103} {Pfam: Repeat of unknown function (DUF1502) [PF07397.13, score=29.2]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=86.7, Expect=2e-18]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_071050 {REF} {Length: 668} {TRANSSPLICED} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=32.5]} {RNA1509_21624} {RNA1310_7883} {RNA815_36144} |
|
7. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
1.812 | - | - | 0.840 | - | 0.972 | - | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
8. | MligTC455_26411 | 55 | 1.14 | Mlig455_024911 | Neo: - Age: - |
1.806 | - | - | 0.824 | - | 0.982 | - | Mlig455_024911 {REF} {Length: 2411} {Pfam: SH3 domain [PF00018.30, score=28.9]; Variant SH3 domain [PF14604.8, score=22.2]; Variant SH3 domain [PF07653.19, score=22.1]} {Smed: dd_Smed_v6_8729_0_1, dd_Smed_v6_8729_0_1, [RH, Score=60.1, Expect=5e-10]} {RNA1310_32104} {RNA815_32970} | |
9. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
1.758 | - | - | 0.779 | - | 0.979 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
10. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
1.756 | - | - | 0.780 | - | 0.976 | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
11. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
1.745 | - | - | 0.747 | - | 0.998 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
12. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
1.737 | - | - | 0.744 | - | 0.993 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
13. | MligTC455_17633 | 25 | 0.51 | Mlig455_066373 | Neo: - Age: - |
RHBG | 1.734 | - | - | 0.734 | - | 1.000 | - | Mlig455_066373 {REF} {Length: 1855} {Pfam: Ammonium Transporter Family [PF00909.23, score=389.0]} {Human: ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=60.8, Expect=3e-09]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [RH, Score=459, Expect=5e-157]} {Celegans: WBGene00000135, amt-3, Putative ammonium transporter 3, [RH, Score=401, Expect=1e-132]} {RNA1310_75971} {RNA815_45087} |
14. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 1.734 | - | - | 0.760 | - | 0.974 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
15. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
1.733 | - | - | 0.767 | - | 0.966 | - | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
16. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 1.732 | - | - | 0.733 | - | 0.999 | - | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
17. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 1.728 | - | - | 0.739 | - | 0.989 | - | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
18. | MligTC455_45624 | 141 | 2.93 | Mlig455_033884, Mlig455_033892, Mlig455_033911 | Neo: Int S/G2/M Age: - |
GLRA1, GLRA3 | 1.722 | - | - | 0.758 | - | 0.964 | - | Mlig455_033884 {REF} {Length: 3237} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=129.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=62.8]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=242, Expect=6e-75]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=240, Expect=3e-74]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=233, Expect=3e-71]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=241, Expect=9e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=235, Expect=6e-72]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=233, Expect=2e-71]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=232, Expect=5e-71]} {Dmel: FBgn0024963, GluClalpha, [Score=220, Expect=1e-66]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=215, Expect=3e-65]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=260, Expect=3e-82]} {RNA1509_59352} {RNA1310_20063, RNA1509_59352} {RNA1509_59352, RNA815_17313} Mlig455_033892 {REF} {Length: 3559} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=129.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=63.1]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=240, Expect=4e-74]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=240, Expect=4e-74]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=233, Expect=2e-71]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=239, Expect=8e-74]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=235, Expect=7e-72]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=233, Expect=2e-71]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=232, Expect=4e-71]} {Dmel: FBgn0024963, GluClalpha, [Score=220, Expect=1e-66]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=215, Expect=3e-65]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=260, Expect=2e-82]} {RNA1509_59352} {RNA1310_20063} {RNA815_17313} Mlig455_033911 {REF} {Length: 2594} {NoTransDecoderORF} {RNA1509_59352} {RNA1310_43340} {RNA815_27918} |
19. | MligTC455_15771 | 15 | 0.31 | Mlig455_013616 | Neo: - Age: - |
1.721 | - | - | 0.747 | - | 0.974 | - | Mlig455_013616 {REF} {Length: 1678} {Pfam: Glycine rich protein [PF12810.9, score=28.8]} {RNA1509_48637} {RNA1310_55197} {RNA815_27869} | |
20. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 1.721 | - | - | 0.740 | - | 0.981 | - | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
21. | MligTC455_18100 | 17 | 0.36 | Mlig455_069127 | Neo: - Age: - |
PPA1 | 1.72 | - | - | 0.734 | - | 0.986 | - | Mlig455_069127 {REF} {Length: 2015} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1509_39915} {RNA1310_57333.1} {RNA815_22340} |
22. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
1.716 | - | - | 0.716 | - | 1.000 | - | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
23. | MligTC455_21227 | 18 | 0.37 | Mlig455_018373 | Neo: - Age: - |
RGS6 | 1.716 | - | - | 0.718 | - | 0.998 | - | Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067} |
24. | MligTC455_44372 | 319 | 6.64 | Mlig455_016467 | Neo: - Age: - Region-enriched R2: 2.783/0.04502 |
1.716 | - | - | 0.760 | - | 0.956 | - | Mlig455_016467 {REF} {Length: 3430} {Pfam: Innexin [PF00876.20, score=423.2]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=107, Expect=2e-25]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=332, Expect=1e-110]} {Smed: dd_Smed_v6_6114_0_1, dd_Smed_v6_6114_0_1, [RH, Score=569, Expect=0.0]} {RNA1509_40288} {RNA1310_5443} {RNA815_16099} | |
25. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.713 | - | - | 0.716 | - | 0.997 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
26. | MligTC455_12126 | 26 | 0.55 | Mlig455_040946 | Neo: - Age: - |
1.707 | - | - | 0.719 | - | 0.988 | - | Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956} | |
27. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
1.706 | - | - | 0.737 | - | 0.969 | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
28. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.705 | - | - | 0.719 | - | 0.986 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
29. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.704 | - | - | 0.712 | - | 0.992 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
30. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.704 | - | - | 0.708 | - | 0.996 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
31. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.703 | - | - | 0.732 | - | 0.971 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
32. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
1.699 | - | - | 0.725 | - | 0.974 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
33. | MligTC455_19917 | 83 | 1.72 | Mlig455_057932, Mlig455_057967 | Neo: - Age: - |
1.699 | - | - | 0.705 | - | 0.994 | - | Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417} Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417} |
|
34. | MligTC455_09457 | 18 | 0.37 | Mlig455_030003 | Neo: - Age: - |
1.697 | - | - | 0.719 | - | 0.978 | - | Mlig455_030003 {REF} {Length: 1601} {RNA1509_44134} {RNA1310_63608.1} {RNA815_45870} | |
35. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 1.697 | - | - | 0.731 | - | 0.966 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
36. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
1.697 | - | - | 0.724 | - | 0.973 | - | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
37. | MligTC455_46155 | 116 | 2.42 | Mlig455_027239 | Neo: - Age: - Region-enriched R2: 4.163/0.03818 |
GRK3 | 1.695 | - | - | 0.745 | - | 0.950 | - | Mlig455_027239 {REF} {Length: 2919} {Pfam: Protein kinase domain [PF00069.27, score=226.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=100.5]; Regulator of G protein signaling domain [PF00615.21, score=48.3]} {Human: ENSG00000100077, GRK3, G protein-coupled receptor kinase 3, [Score=845, Expect=0.0]; ENSG00000173020, GRK2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Mouse: ENSMUSG00000042249, Grk3, G protein-coupled receptor kinase 3, [Score=838, Expect=0.0]; ENSMUSG00000024858, Grk2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Dmel: FBgn0260798, Gprk1, G protein-coupled receptor kinase 1, [Score=842, Expect=0.0]} {Celegans: WBGene00001709, grk-2, G protein-coupled receptor kinase 2, [Score=819, Expect=0.0]} {Smed: dd_Smed_v6_6480_0_1, dd_Smed_v6_6480_0_1, [Score=949, Expect=0.0]} {RNA1509_7002} {RNA1310_16658} {RNA815_28070} |
38. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
1.688 | - | - | 0.703 | - | 0.985 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
39. | MligTC455_12673 | 10 | 0.2 | Mlig455_003447 | Neo: - Age: - |
1.687 | - | - | 0.703 | - | 0.984 | - | Mlig455_003447 {REF} {Length: 1947} {RNA1509_51609} {RNA1310_3461} {RNA815_16498} | |
40. | MligTC455_52814 | 47 | 0.97 | Mlig455_047356, Mlig455_047365 | Neo: - Age: - |
CNTN2 | 1.685 | - | - | 0.718 | - | 0.967 | - | Mlig455_047356 {REF} {Length: 2537} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.8]; Immunoglobulin domain [PF13927.8, score=52.6]; Immunoglobulin domain [PF13895.8, score=40.4]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.9]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=56.6, Expect=8e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.1, Expect=2e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=54.7, Expect=3e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=58.2, Expect=2e-08]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=2e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_18728} Mlig455_047365 {REF} {Length: 3489} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.9]; Immunoglobulin domain [PF13927.8, score=52.8]; Immunoglobulin domain [PF13895.8, score=40.5]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.4]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=55.5, Expect=1e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=53.9, Expect=5e-07]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=53.5, Expect=6e-07]; ENSMUSG00000055022, Cntn1, contactin 1, [Score=52.8, Expect=1e-06]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=1e-06]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=55.5, Expect=1e-07]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=1e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_19521} |
41. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 1.68 | - | - | 0.701 | - | 0.979 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
42. | MligTC455_53435 | 190 | 3.96 | Mlig455_045425, Mlig455_065748 | Neo: - Age: - Region-enriched R2: 4.111/0.00023 |
SYT9 | 1.68 | - | - | 0.722 | - | 0.958 | - | Mlig455_045425 {REF} {Length: 2615} {RNA1509_46689} {RNA1310_15031, RNA1509_46689} {RNA1509_46689, RNA815_18779.1} Mlig455_065748 {REF} {Length: 3143} {Pfam: C2 domain [PF00168.32, score=116.1]} {Human: ENSG00000170743, SYT9, synaptotagmin 9, [Score=162, Expect=4e-42]; ENSG00000213023, SYT3, synaptotagmin 3, [Score=157, Expect=5e-40]} {Mouse: ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=162, Expect=3e-42]; ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=156, Expect=1e-39]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [RH, Score=197, Expect=1e-54]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=144, Expect=8e-37]} {Smed: dd_Smed_v6_6730_0_1, dd_Smed_v6_6730_0_1, [Score=155, Expect=5e-41]} {RNA1509_46689} {RNA1310_15031} {RNA815_18779.1} |
43. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
1.676 | - | - | 0.702 | - | 0.974 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
44. | MligTC455_07029 | 51 | 1.07 | Mlig455_030754 | Neo: - Age: Up-Down-Down |
KIF1A | 1.675 | - | - | 0.722 | - | 0.953 | - | Mlig455_030754 {REF} {Length: 6754} {Pfam: Kinesin motor domain [PF00225.25, score=361.6]; Kinesin-associated [PF16183.7, score=198.6]; Kinesin protein [PF12473.10, score=104.3]; Microtubule binding [PF16796.7, score=63.6]; PH domain [PF00169.31, score=42.1]; Kinesin protein 1B [PF12423.10, score=37.6]; FHA domain [PF00498.28, score=32.6]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=26.1]} {Human: ENSG00000130294, KIF1A, kinesin family member 1A, [Score=1405, Expect=0.0]} {Mouse: ENSMUSG00000014602, Kif1a, kinesin family member 1A, [Score=1404, Expect=0.0]} {Dmel: FBgn0267002, unc-104, uncoordinated-104, [Score=1415, Expect=0.0]} {Celegans: WBGene00006831, unc-104, Kinesin-like protein unc-104, [RH, Score=1292, Expect=0.0]} {Smed: dd_Smed_v6_7108_0_2, dd_Smed_v6_7108_0_2, [Score=1552, Expect=0.0]} {RNA1509_24107} {RNA1310_2896} {RNA815_13100} |
45. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
1.672 | - | - | 0.701 | - | 0.971 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
46. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 1.671 | - | - | 0.705 | - | 0.966 | - | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
47. | MligTC455_14293 | 27 | 0.55 | Mlig455_005699 | Neo: - Age: - |
1.666 | - | - | 0.716 | - | 0.950 | - | Mlig455_005699 {REF} {Length: 220} {NoTransDecoderORF} {RNA1509_35414} {RNA1310_4580} | |
48. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 1.664 | - | - | 0.702 | - | 0.962 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
49. | MligTC455_10953 | 148 | 3.08 | Mlig455_060864, Mlig455_063528 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.497/0.01237 |
KCNH7 | 1.663 | - | - | 0.709 | - | 0.954 | - | Mlig455_060864 {REF} {Length: 7144} {Pfam: Ion transport protein [PF00520.33, score=117.5]; Cyclic nucleotide-binding domain [PF00027.31, score=52.7]; Ion channel [PF07885.18, score=45.4]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=777, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=760, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=751, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=776, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=761, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=751, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=712, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=798, Expect=0.0]} {RNA1509_40124} {RNA1310_4074} {RNA815_8044} Mlig455_063528 {REF} {Length: 734} {NoTransDecoderORF} |
50. | MligTC455_51178 | 190 | 3.97 | Mlig455_066114 | Neo: - Age: - |
1.663 | - | - | 0.706 | - | 0.957 | - | Mlig455_066114 {REF} {Length: 2408} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=58.5, Expect=4e-10]} {RNA1509_36492} {RNA1310_14560, RNA1509_36492} {RNA1509_36492, RNA815_5366} | |
51. | MligTC455_14842 | 21 | 0.45 | Mlig455_041074 | Neo: - Age: - |
1.658 | - | - | 0.701 | - | 0.957 | - | Mlig455_041074 {REF} {Length: 1383} {RNA1310_60383} {RNA815_48502} | |
52. | MligTC455_45123 | 17 | 0.35 | Mlig455_003259, Mlig455_062838 | Neo: - Age: - |
1.654 | - | - | 0.704 | - | 0.950 | - | Mlig455_003259 {REF} {Length: 988} {Pfam: WSC domain [PF01822.21, score=59.6]; PAN domain [PF00024.28, score=21.3]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=61.2, Expect=1e-10]} {RNA1509_42596} {RNA1310_44497} {RNA815_21593} Mlig455_062838 {REF} {Length: 844} {Pfam: PAN domain [PF00024.28, score=27.6]} {RNA1509_39816} {RNA1310_44497} {RNA815_21593} |
|
53. | MligTC455_53741 | 27 | 0.57 | Mlig455_014136 | Neo: - Age: - |
POMGNT1 | 1.651 | - | - | 0.701 | - | 0.950 | - | Mlig455_014136 {REF} {Length: 2328} {Pfam: GNT-I family [PF03071.17, score=64.4]} {Human: ENSG00000085998, POMGNT1, protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), [RH, Score=212, Expect=3e-59]} {Mouse: ENSMUSG00000028700, Pomgnt1, protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase, [RH, Score=211, Expect=2e-59]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=65.5, Expect=6e-11]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=60.5, Expect=2e-09]} {Smed: dd_Smed_v6_17617_0_1, dd_Smed_v6_17617_0_1, [RH, Score=179, Expect=1e-48]} {RNA1310_40753} {RNA815_46657} |
54. | MligTC455_00004 | 4 | 0.09 | Mlig455_047925 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_047925 {REF} {Length: 117} {NoTransDecoderORF} | |
55. | MligTC455_00637 | 4 | 0.09 | Mlig455_016387 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_016387 {REF} {Length: 629} {NoTransDecoderORF} {RNA1310_114311} | |
56. | MligTC455_01229 | 5 | 0.1 | Mlig455_013929 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_013929 {REF} {Length: 1302} {NoTransDecoderORF} | |
57. | MligTC455_01285 | 3 | 0.05 | Mlig455_064687 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_064687 {REF} {Length: 806} {NoTransDecoderORF} | |
58. | MligTC455_01440 | 4 | 0.07 | Mlig455_002048 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_002048 {REF} {Length: 231} {NoTransDecoderORF} {RNA1310_53208} | |
59. | MligTC455_01727 | 6 | 0.14 | Mlig455_034612 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_034612 {REF} {Length: 1062} {Pfam: Interferon-induced transmembrane protein [PF04505.14, score=24.1]} {RNA1310_112233} | |
60. | MligTC455_02055 | 7 | 0.14 | Mlig455_039229 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_039229 {REF} {Length: 341} {NoTransDecoderORF} {RNA1509_8341} {RNA1310_7032.2} | |
61. | MligTC455_02056 | 6 | 0.12 | Mlig455_039246 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_039246 {REF} {Length: 249} {NoTransDecoderORF} {RNA1509_8341} {RNA1310_7032.2} | |
62. | MligTC455_02772 | 4 | 0.08 | Mlig455_038473 | Neo: - Age: - |
FEV | 1 | - | - | - | - | 1.000 | - | Mlig455_038473 {REF} {Length: 1322} {Pfam: Ets-domain [PF00178.24, score=118.7]; Protein of unknown function (DUF2722) [PF10846.10, score=18.2]} {Human: ENSG00000163497, FEV, FEV, ETS transcription factor, [RH, Score=186, Expect=2e-57]} {Mouse: ENSMUSG00000055197, Fev, FEV (ETS oncogene family), [RH, Score=186, Expect=1e-57]} {Dmel: FBgn0005658, Ets65A, Ets at 65A, [Score=207, Expect=2e-65]} {Celegans: WBGene00020368, ast-1, Axon STeering defect, [RH, Score=196, Expect=4e-60]} {Smed: dd_Smed_v6_14611_0_1, dd_Smed_v6_14611_0_1, [RH, Score=211, Expect=7e-65]} {RNA1509_29423} {RNA1310_30786.1} {RNA815_45406} |
63. | MligTC455_02847 | 2 | 0.04 | Mlig455_065269 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_065269 {REF} {Length: 1289} {Smed: dd_Smed_v6_5211_0_1, dd_Smed_v6_5211_0_1, [Score=45.8, Expect=1e-06]} {RNA1310_10378.1} | |
64. | MligTC455_04052 | 5 | 0.11 | Mlig455_004868 | Neo: - Age: Up-Down-Down |
TIAM1 | 1 | - | - | - | - | 1.000 | - | Mlig455_004868 {REF} {Length: 3920} {Pfam: PH domain [PF00169.31, score=54.3]; Pleckstrin homology domain [PF15410.8, score=37.6]; PDZ domain [PF17820.3, score=29.3]; RhoGEF domain [PF00621.22, score=25.1]; PDZ domain [PF00595.26, score=20.8]; PDZ domain [PF13180.8, score=20.1]} {Human: ENSG00000156299, TIAM1, T cell lymphoma invasion and metastasis 1, [Score=201, Expect=8e-52]} {Mouse: ENSMUSG00000002489, Tiam1, T cell lymphoma invasion and metastasis 1, [Score=159, Expect=2e-39]; ENSMUSG00000023800, Tiam2, T cell lymphoma invasion and metastasis 2, [Score=152, Expect=6e-37]} {Dmel: FBgn0085447, sif, still life, [Score=167, Expect=8e-42]} {RNA1310_14754.3} {RNA815_36642} |
65. | MligTC455_04760 | 3 | 0.07 | Mlig455_066971 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_066971 {REF} {Length: 460} {RNA1509_15765} {RNA1310_34489} | |
66. | MligTC455_05005 | 3 | 0.07 | Mlig455_008576, Mlig455_053579 | Neo: - Age: - |
NYNRIN | 1 | - | - | - | - | 1.000 | - | Mlig455_008576 {REF} {Length: 2428} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=106.8]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=100.4]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=65.4]; Integrase zinc binding domain [PF17921.3, score=59.9]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=228, Expect=6e-64]} {RNA1509_56234} {RNA1310_4326.1} {RNA815_14392} Mlig455_053579 {REF} {Length: 2465} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=106.6]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.9]; Integrase zinc binding domain [PF17921.3, score=55.6]; Integrase core domain [PF00665.28, score=50.0]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=35.4]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=52.4, Expect=4e-06]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=53.1, Expect=1e-06]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=208, Expect=6e-56]} {RNA1509_56234} {RNA1310_4313.1} {RNA815_29579} |
67. | MligTC455_05148 | 2 | 0.05 | Mlig455_006400 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_006400 {REF} {Length: 1065} {NoTransDecoderORF} {RNA1310_91352.1} | |
68. | MligTC455_05183 | 13 | 0.27 | Mlig455_003637 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_003637 {REF} {Length: 906} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [Score=57.0, Expect=8e-10]} {RNA1310_45613} {RNA815_17816.1} | |
69. | MligTC455_05893 | 3 | 0.06 | Mlig455_027713, Mlig455_027915 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_027713 {REF} {Length: 330} {NoTransDecoderORF} Mlig455_027915 {REF} {Length: 330} {NoTransDecoderORF} |
|
70. | MligTC455_05965 | 5 | 0.11 | Mlig455_011455, Mlig455_011536 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_011455 {REF} {Length: 1967} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=37.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.4]} {Dmel: FBgn0034168, CG15614, [Score=64.3, Expect=9e-11]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=48.5, Expect=7e-06]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [Score=126, Expect=3e-32]} {RNA1310_121803} Mlig455_011536 {REF} {Length: 2228} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=37.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.4]} {Dmel: FBgn0034168, CG15614, [Score=64.3, Expect=8e-11]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=48.5, Expect=6e-06]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [Score=126, Expect=3e-32]} {RNA1310_121803} |
|
71. | MligTC455_06066 | 8 | 0.17 | Mlig455_013274 | Neo: - Age: logFC(26M/2M)=-0.892 |
1 | - | - | - | - | 1.000 | - | Mlig455_013274 {REF} {Length: 2539} {RNA1509_20101} {RNA1310_11152} {RNA815_6896} | |
72. | MligTC455_06358 | 3 | 0.06 | Mlig455_059456 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_059456 {REF} {Length: 590} {NoTransDecoderORF} | |
73. | MligTC455_06462 | 15 | 0.32 | Mlig455_040723 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_040723 {REF} {Length: 560} {NoTransDecoderORF} {RNA1310_64084} {RNA815_33076} | |
74. | MligTC455_06633 | 4 | 0.08 | Mlig455_013714 | Neo: - Age: - |
TANC2 | 1 | - | - | - | - | 1.000 | - | Mlig455_013714 {REF} {Length: 1703} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=47.8]; Ankyrin repeats (many copies) [PF13637.8, score=43.1]; Ankyrin repeats (many copies) [PF13857.8, score=30.2]; Ankyrin repeat [PF00023.32, score=24.3]; Ankyrin repeat [PF13606.8, score=24.2]} {Human: ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=74.3, Expect=3e-13]} {Mouse: ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=71.2, Expect=2e-12]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=55.8, Expect=7e-08]} {Smed: dd_Smed_v6_8675_0_1, dd_Smed_v6_8675_0_1, [Score=66.2, Expect=3e-11]} {RNA1310_114995} |
75. | MligTC455_06688 | 2 | 0.04 | Mlig455_033105 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_033105 {REF} {Length: 1140} {Smed: dd_Smed_v6_12949_0_1, dd_Smed_v6_12949_0_1, [RH, Score=76.3, Expect=6e-17]} {RNA1310_117049} | |
76. | MligTC455_07456 | 2 | 0.04 | Mlig455_000721, Mlig455_005160, Mlig455_016787, Mlig455_065289 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_000721 {REF} {Length: 1415} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=105.5]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=80.1]; Integrase core domain [PF13683.8, score=24.9]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.1]} {Smed: dd_Smed_v6_15498_0_18, dd_Smed_v6_15498_0_18, [Score=80.5, Expect=1e-16]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_24380} Mlig455_005160 {REF} {Length: 1577} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=105.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=79.4]; Integrase core domain [PF13683.8, score=23.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=20.9]} {Smed: dd_Smed_v6_15498_0_18, dd_Smed_v6_15498_0_18, [Score=83.2, Expect=2e-17]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_24380} Mlig455_016787 {REF} {Length: 1715} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=92.3]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=77.2]; Integrase core domain [PF00665.28, score=29.8]; Integrase core domain [PF13683.8, score=24.6]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=75.5, Expect=1e-14]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_24529} Mlig455_065289 {REF} {Length: 1388} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=94.7]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=80.1]; Integrase core domain [PF00665.28, score=30.3]; Integrase core domain [PF13683.8, score=25.0]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=21.2]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=75.5, Expect=9e-15]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_62340} |
|
77. | MligTC455_07457 | 2 | 0.04 | Mlig455_044770, Mlig455_053668, Mlig455_064580, Mlig455_065313 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_044770 {REF} {Length: 1145} {Pfam: Integrase core domain [PF00665.28, score=31.2]; Integrase core domain [PF13683.8, score=25.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=21.6]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=73.6, Expect=2e-14]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_62340} Mlig455_053668 {REF} {Length: 1472} {Pfam: Integrase core domain [PF00665.28, score=30.6]; Integrase core domain [PF13683.8, score=25.0]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=73.9, Expect=4e-14]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_24529} Mlig455_064580 {REF} {Length: 1001} {Pfam: Integrase core domain [PF13683.8, score=25.4]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=21.8]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=65.5, Expect=7e-12]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_24380} Mlig455_065313 {REF} {Length: 1388} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=94.7]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=80.1]; Integrase core domain [PF00665.28, score=30.3]; Integrase core domain [PF13683.8, score=25.0]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=21.2]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=75.5, Expect=9e-15]} {RNA1509_44393} {RNA1310_15428.2} {RNA815_62340} |
|
78. | MligTC455_07681 | 11 | 0.24 | Mlig455_028257 | Neo: - Age: - |
HCN4 | 1 | - | - | - | - | 1.000 | - | Mlig455_028257 {REF} {Length: 2915} {Pfam: Ion transport protein [PF00520.33, score=85.6]; Ion transport protein N-terminal [PF08412.12, score=78.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.1]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [RH, Score=635, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [RH, Score=615, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [RH, Score=630, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [RH, Score=615, Expect=0.0]; ENSMUSG00000021730, Hcn1, hyperpolarization-activated, cyclic nucleotide-gated K+ 1, [RH, Score=604, Expect=0.0]; ENSMUSG00000028051, Hcn3, hyperpolarization-activated, cyclic nucleotide-gated K+ 3, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=777, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=186, Expect=6e-49]} {Smed: dd_Smed_v6_13408_0_1, dd_Smed_v6_13408_0_1, [RH, Score=910, Expect=0.0]} {RNA1509_59211} {RNA1310_21771.2} {RNA815_15561.1} |
79. | MligTC455_07705 | 6 | 0.13 | Mlig455_012841 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_012841 {REF} {Length: 1042} {Smed: dd_Smed_v6_38985_0_1, dd_Smed_v6_38985_0_1, [Score=54.3, Expect=9e-09]} {RNA1310_136328} | |
80. | MligTC455_07976 | 9 | 0.19 | Mlig455_026945 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_026945 {REF} {Length: 1312} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.6]} {RNA1310_34740} {RNA815_15663} | |
81. | MligTC455_07989 | 5 | 0.11 | Mlig455_041885 | Neo: - Age: - |
FMO5 | 1 | - | - | - | - | 1.000 | - | Mlig455_041885 {REF} {Length: 2750} {Pfam: Flavin-binding monooxygenase-like [PF00743.21, score=374.5]; Pyridine nucleotide-disulphide oxidoreductase [PF13738.8, score=52.1]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=44.4]; L-lysine 6-monooxygenase (NADPH-requiring) [PF13434.8, score=35.5]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.5]; FAD-NAD(P)-binding [PF13454.8, score=20.1]} {Human: ENSG00000131781, FMO5, flavin containing monooxygenase 5, [Score=320, Expect=1e-102]; ENSG00000094963, FMO2, flavin containing monooxygenase 2, [Score=311, Expect=2e-99]} {Mouse: ENSMUSG00000028088, Fmo5, flavin containing monooxygenase 5, [Score=328, Expect=5e-106]; ENSMUSG00000026560, Fmo9, flavin containing monooxygenase 9, [Score=318, Expect=6e-102]} {Dmel: FBgn0033079, Fmo-2, Flavin-containing monooxygenase 2, [Score=112, Expect=2e-26]} {Celegans: WBGene00001477, fmo-2, Flavin-containing monooxygenase, [Score=278, Expect=8e-87]} {Smed: dd_Smed_v6_9449_0_1, dd_Smed_v6_9449_0_1, [Score=98.2, Expect=8e-22]} |
82. | MligTC455_08050 | 3 | 0.06 | Mlig455_033940 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_033940 {REF} {Length: 1586} {RNA1310_82051} {RNA815_21626} | |
83. | MligTC455_08236 | 3 | 0.06 | Mlig455_067543 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_067543 {REF} {Length: 321} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_54990} | |
84. | MligTC455_08442 | 15 | 0.31 | Mlig455_018498 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_018498 {REF} {Length: 550} {NoTransDecoderORF} | |
85. | MligTC455_08468 | 5 | 0.1 | Mlig455_049616 | Neo: - Age: - |
CASR | 1 | - | - | - | - | 1.000 | - | Mlig455_049616 {REF} {Length: 2582} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=91.7]; Receptor family ligand binding region [PF01094.30, score=81.9]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=41.2]; Periplasmic binding protein [PF13458.8, score=25.1]} {Human: ENSG00000036828, CASR, calcium sensing receptor, [Score=107, Expect=4e-23]} {Mouse: ENSMUSG00000027824, Vmn2r1, vomeronasal 2, receptor 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0050361, mtt, mangetout, [Score=151, Expect=3e-37]} {Celegans: WBGene00003233, mgl-2, Metabotropic GLutamate receptor family, [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_32826_0_1, dd_Smed_v6_32826_0_1, [Score=66.6, Expect=4e-11]} {RNA1310_116747} |
86. | MligTC455_08675 | 2 | 0.04 | Mlig455_009734 | Neo: Irradiation Age: Up-Down-Down |
ANKRD24 | 1 | - | - | - | - | 1.000 | - | Mlig455_009734 {REF} {Length: 3249} {Human: ENSG00000089847, ANKRD24, ankyrin repeat domain 24, [Score=50.8, Expect=9e-07]} {RNA1310_111731} |
87. | MligTC455_08776 | 5 | 0.11 | Mlig455_039547, Mlig455_051351 | Neo: - Age: - |
KCNK18 | 1 | - | - | - | - | 1.000 | - | Mlig455_039547 {REF} {Length: 3649} {Pfam: Ion channel [PF07885.18, score=115.5]; Ion transport protein [PF00520.33, score=30.1]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=69.3, Expect=8e-12]} {Dmel: FBgn0033257, sand, sandman, [Score=115, Expect=4e-27]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=111, Expect=3e-26]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=183, Expect=5e-49]} {RNA1509_36763} {RNA1310_59385} {RNA815_54618} Mlig455_051351 {REF} {Length: 4033} {Pfam: Ion channel [PF07885.18, score=115.5]; Ion transport protein [PF00520.33, score=30.1]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=69.3, Expect=8e-12]} {Dmel: FBgn0033257, sand, sandman, [Score=115, Expect=4e-27]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=111, Expect=3e-26]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=183, Expect=6e-49]} {RNA1509_15265} {RNA1310_41793} {RNA815_54785} |
88. | MligTC455_08958 | 6 | 0.12 | Mlig455_043923 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_043923 {REF} {Length: 1322} {Pfam: TRP-interacting helix [PF15018.8, score=33.5]} {RNA1310_133937} | |
89. | MligTC455_09113 | 7 | 0.14 | Mlig455_008096, Mlig455_015585 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_008096 {REF} {Length: 720} {RNA1310_149697} Mlig455_015585 {REF} {Length: 720} {RNA1310_149697} |
|
90. | MligTC455_09442 | 12 | 0.24 | Mlig455_065765 | Neo: - Age: - |
GABBR2 | 1 | - | - | - | - | 1.000 | - | Mlig455_065765 {REF} {Length: 2959} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=146.7]; Receptor family ligand binding region [PF01094.30, score=114.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=285, Expect=7e-82]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=280, Expect=4e-80]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=239, Expect=2e-65]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=222, Expect=1e-60]} {Smed: dd_Smed_v6_20665_0_1, dd_Smed_v6_20665_0_1, [Score=140, Expect=6e-34]} {RNA1509_58025} {RNA1310_57812} {RNA815_11540} |
91. | MligTC455_09520 | 13 | 0.27 | Mlig455_028189, Mlig455_028259 | Neo: - Age: - |
ADRA1A | 1 | - | - | - | - | 1.000 | - | Mlig455_028189 {REF} {Length: 1539} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=273.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=35.4]; Olfactory receptor [PF13853.8, score=25.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.9]} {Human: ENSG00000120907, ADRA1A, adrenoceptor alpha 1A, [RH, Score=311, Expect=6e-101]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [RH, Score=300, Expect=3e-96]} {Mouse: ENSMUSG00000045875, Adra1a, adrenergic receptor, alpha 1a, [RH, Score=311, Expect=3e-101]; ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [RH, Score=301, Expect=1e-96]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [Score=218, Expect=1e-64]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=202, Expect=4e-60]} {Smed: dd_Smed_v6_31015_0_1, dd_Smed_v6_31015_0_1, [RH, Score=248, Expect=4e-78]} {RNA1310_126346} Mlig455_028259 {REF} {Length: 1539} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=273.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=35.4]; Olfactory receptor [PF13853.8, score=25.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.9]} {Human: ENSG00000120907, ADRA1A, adrenoceptor alpha 1A, [RH, Score=311, Expect=6e-101]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [RH, Score=300, Expect=3e-96]} {Mouse: ENSMUSG00000045875, Adra1a, adrenergic receptor, alpha 1a, [RH, Score=311, Expect=3e-101]; ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [RH, Score=301, Expect=1e-96]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [Score=218, Expect=1e-64]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=202, Expect=4e-60]} {Smed: dd_Smed_v6_31015_0_1, dd_Smed_v6_31015_0_1, [RH, Score=248, Expect=4e-78]} |
92. | MligTC455_09521 | 5 | 0.1 | Mlig455_034851 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_034851 {REF} {Length: 413} {NoTransDecoderORF} {RNA1509_51801} {RNA1310_44051} {RNA815_43534} | |
93. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 1 | - | - | - | - | 1.000 | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
94. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 1 | - | - | - | - | 1.000 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
95. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
96. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
97. | MligTC455_10968 | 7 | 0.14 | Mlig455_015698 | Neo: - Age: - |
HMCN1 | 1 | - | - | - | - | 1.000 | - | Mlig455_015698 {REF} {Length: 1150} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=52.4, Expect=5e-07]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=60.5, Expect=6e-10]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [Score=51.6, Expect=2e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=60.1, Expect=4e-10]} {RNA1310_100476} {RNA815_63742} |
98. | MligTC455_11004 | 32 | 0.67 | Mlig455_054795, Mlig455_054889 | Neo: Irradiation |
1 | - | - | - | - | 1.000 | - | Mlig455_054795 {REF} {Length: 1436} {RNA1509_22234, RNA1509_40720} {RNA1310_32042, RNA1509_22234} {RNA1509_22234, RNA815_14622} Mlig455_054889 {REF} {Length: 1375} {RNA1509_22234} {RNA1310_32042} {RNA815_14622} |
|
99. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 1 | - | - | - | - | 1.000 | - | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
100. | MligTC455_11383 | 5 | 0.1 | Mlig455_042722 | Neo: - Age: - |
GRIK1 | 1 | - | - | - | - | 1.000 | - | Mlig455_042722 {REF} {Length: 2104} {Pfam: Ligand-gated ion channel [PF00060.28, score=57.8]; Receptor family ligand binding region [PF01094.30, score=49.5]} {Human: ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=63.2, Expect=1e-09]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=63.2, Expect=1e-09]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=60.1, Expect=1e-08]} {Mouse: ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=63.9, Expect=5e-10]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=63.2, Expect=8e-10]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=78.6, Expect=1e-14]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=57.0, Expect=3e-08]} {Smed: dd_Smed_v6_52857_0_1, dd_Smed_v6_52857_0_1, [Score=135, Expect=4e-35]} {RNA1310_25150} {RNA815_13999} |